BioRestorative Therapies GAAP EPS of -$0.33 misses by $0.03, revenue of $0.01M misses by $0.51M
Source: SeekingAlpha
2025-11-13 12:46:55 ET
More on BioRestorative Therapies
- BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript
- BioRestorative outlines BioCosmeceuticals expansion with new leadership and eyes $63B market opportunity
- Seeking Alpha’s Quant Rating on BioRestorative Therapies
- Historical earnings data for BioRestorative Therapies
- Financial information for BioRestorative Therapies
Read the full article on Seeking Alpha
For further details see:
BioRestorative Therapies GAAP EPS of -$0.33 misses by $0.03, revenue of $0.01M misses by $0.51M
BioRestorative Therapies Inc
NASDAQ: BRTX
BRTX Trading
-2.26% G/L:
$0.2901 Last:
1,689,480 Volume:
$0.3074 Open:
BRTX Latest News
March 05, 2026 08:00:00 am
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
March 04, 2026 08:00:00 am
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
BRTX Stock Data
$5,858,320
6,390,894
0.26%
5
N/A
Biotechnology & Life Sciences
Healthcare
US
Melville
